Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group

Through BSPG’s industrial-sized, proprietary extraction methodologies, BSPG produces high-purity, bioactive cannabinoids that are used in pharmaceutical applications to benefit those suffering from a range of life-threatening and non-life-threatening illnesses. BSPG is currently conducting clinical trials … Read More

The post Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group appeared first on Dagga Magazine.

…read more

Leave a Reply

Your email address will not be published. Required fields are marked *